Strain Information | |
---|---|
Image | |
BRC No. | RBRC05751 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | C57BL/6N-Ttll8<tm1Seto> |
Former Common name | TTLL8 KO, B6-Ttll8 KO |
H-2 Haplotype | |
ES Cell line | RENKA [C57BL/6NCrlCrlj] |
Background strain | C57BL/6NCrlCrlj |
Appearance | |
Strain development | Developed by Koji Ikegami and Mitsutoshi Setou, Medical Photonics Research Center, Hamamatsu University School of Medicine in 2009. RENKA ES cells derived from C57BL/6N were used. |
Strain description | Ttll8 gene knockout mice. Exon1 and 3’UTR terminal region of nearby Mlc1 gene were deleted by homologous recombination. |
Colony maintenance | Heterozygote x Wild-type [C57BL/6NCrlCrlj] |
References | TTLL10 can perform tubulin glycylation when co-expressed with TTLL8. Ikegami K, Setou M FEBS Lett., 583, 1957-1963 (2009). 19427864 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Ttll8 MGI:1922902 | tubulin tyrosine ligase-like family, member 8 | 15 | Ttll8 <tm1Seto> | targeted mutation 1, Mitsutoshi Setou | |||
neo | neomycin resistance gene (E. coli) | 15 | herpes simplex virus thymidine kinase promoter (HSV tk promoter) |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | E. coli Neomycin resistance gene, HSV thymidine kinase promoter, HSV PolyA signal |
Research application | Cell Biology Research |
Specific Term and Conditions | The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for-profit institution for a not-for-profit research. Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. The RECIPIENT must contact the DEPOSITOR prior to publishing the research results obtained by use of the BIOLOGICAL RESOURCE. The RECIPIENT must contact in advance the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. The RECIPIENT must not distribute the BIOLOGICAL RESOURCE and the derivatives to third parties. |
Depositor | Mitsutoshi Setou (Hamamatsu University School of Medicine) |
Strain Status | ![]() |
Strain Availability | Recovered litters from cryopreserved sperm (2 to 4 months) Cryopreserved sperm (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |